Product NDC: | 67457-198 |
Proprietary Name: | Ultiva |
Non Proprietary Name: | Remifentanil Hydrochloride |
Active Ingredient(s): | 1 mg/mL & nbsp; Remifentanil Hydrochloride |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 67457-198 |
Labeler Name: | Mylan Institutional LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020630 |
Marketing Category: | NDA |
Start Marketing Date: | 19960712 |
Package NDC: | 67457-198-03 |
Package Description: | 10 VIAL, GLASS in 1 CARTON (67457-198-03) > 3 mL in 1 VIAL, GLASS (67457-198-00) |
NDC Code | 67457-198-03 |
Proprietary Name | Ultiva |
Package Description | 10 VIAL, GLASS in 1 CARTON (67457-198-03) > 3 mL in 1 VIAL, GLASS (67457-198-00) |
Product NDC | 67457-198 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Remifentanil Hydrochloride |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19960712 |
Marketing Category Name | NDA |
Labeler Name | Mylan Institutional LLC |
Substance Name | REMIFENTANIL HYDROCHLORIDE |
Strength Number | 1 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |